Determinants of Resistance to Checkpoint Inhibitors

by Linda Tran, Dan Theodorescu
Published 2020-02-01

Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis

by Behfar Ehdaie, Dan Theodorescu
Published 2008-01-01

Robot-Assisted Radical Cystectomy in the Management of Bladder Cancer

by Jessica L. Keim, Dan Theodorescu
Published 2006-01-01

Robust prognostic gene expression signatures in bladder cancer and lung adenocarcinoma depend on cell cycle related genes.

by Garrett M Dancik, Dan Theodorescu
Published 2014-01-01

Molecular Credentialing of Rodent Bladder Carcinogenesis Models

by Paul D. Williams, Jae K. Lee, Dan Theodorescu
Published 2008-08-01

Cdc6 and Cyclin E2 Are PTEN-Regulated Genes Associated with Human Prostate Cancer Metastasis

by Zhong Wu, HyungJun Cho, Garret M. Hampton, Dan Theodorescu
Published 2009-01-01

RalBP1 Is Necessary for Metastasis of Human Cancer Cell Lines

by Zhong Wu, Charles Owens, Nidhi Chandra, Kay Popovic, Mark Conaway, Dan Theodorescu
Published 2010-12-01

Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy

by Mathijs P. Scholtes, Florus C. de Jong, Tahlita C. M. Zuiverloon, Dan Theodorescu
Published 2021-01-01

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer

by Florus C. de Jong, Vera C. Rutten, Tahlita C. M. Zuiverloon, Dan Theodorescu
Published 2021-03-01

A gene expression ratio-based diagnostic test for bladder cancer

by Lingsheng Dong, Andrew J Bard, William G Richards, Matthew D Nitz, Dan Theodorescu, et al
Published 2009-01-01

Retrospective analysis of survival improvement by molecular biomarker-based personalized chemotherapy for recurrent ovarian cancer.

by Youngchul Kim, Saketh R Guntupalli, Sun J Lee, Kian Behbakht, Dan Theodorescu, Jae K Lee, Jennifer R Diamond
Published 2014-01-01

Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.

by J Stuart Ferriss, Youngchul Kim, Linda Duska, Michael Birrer, Douglas A Levine, Christopher Moskaluk, Dan Theodorescu, Jae K Lee
Published 2012-01-01

Use of Yeast Chemigenomics and COXEN Informatics in Preclinical Evaluation of Anticancer Agents

by Steven C. Smith, Dmytro M. Havaleshko, Kihyuck Moon, Alexander S. Baras, Jae Lee, Stefan Bekiranov, Daniel J. Burke, Dan Theodorescu
Published 2011-01-01

Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis.

by Sukhwinder Kaur, Navneet Momi, Subhankar Chakraborty, David G Wagner, Adam J Horn, Subodh M Lele, Dan Theodorescu, Surinder K Batra
Published 2014-01-01

A quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressiveness.

by Laura Grau, Jose L Luque-Garcia, Pilar González-Peramato, Dan Theodorescu, Joan Palou, Jesus M Fernandez-Gomez, Marta Sánchez-Carbayo
Published 2013-01-01

A rho GDP dissociation inhibitor produced by apoptotic T-cells inhibits growth of Mycobacterium tuberculosis.

by Sambasivan Venkatasubramanian, Rohan Dhiman, Padmaja Paidipally, Satyanarayana S Cheekatla, Deepak Tripathi, Elwyn Welch, Amy R Tvinnereim, Brenda Jones, Dan Theodorescu, Peter F Barnes, Ramakrishna Vankayalapati
Published 2015-02-01

Comparison of Global versus Epidermal Growth Factor Receptor Pathway Profiling for Prediction of Lapatinib Sensitivity in Bladder Cancer

by Dmytro M. Havaleshko, Steven Christopher Smith, HyungJun Cho, Sooyoung Cheon, Charles R. Owens, Jae K. Lee, Lance A. Liotta, Virginia Espina, Julia D. Wulfkuhle, Emanuel F. Petricoin, Dan Theodorescu
Published 2009-11-01

An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer

by Kenneth H. Gouin, Nathan Ing, Jasmine T. Plummer, Charles J. Rosser, Bassem Ben Cheikh, Catherine Oh, Stephanie S. Chen, Keith Syson Chan, Hideki Furuya, Warren G. Tourtellotte, Simon R. V. Knott, Dan Theodorescu
Published 2021-08-01

Cyclophilin B Expression Is Associated with In Vitro Radioresistance and Clinical Outcome after Radiotherapy

by Paul D. Williams, Charles R. Owens, Jaroslaw Dziegielewski, Christopher A. Moskaluk, Paul W. Read, James M. Larner, Michael D. Story, William A. Brock, Sally A. Amundson, Jae K. Lee, Dan Theodorescu
Published 2011-12-01

Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.

by David J DeGraff, Peter E Clark, Justin M Cates, Hironobu Yamashita, Victoria L Robinson, Xiuping Yu, Mark E Smolkin, Sam S Chang, Michael S Cookson, Mary K Herrick, Shahrokh F Shariat, Gary D Steinberg, Henry F Frierson, Xue-Ru Wu, Dan Theodorescu, Robert J Matusik
Published 2012-01-01